Artivion, Inc. (NYSE:AORT – Get Rating) VP Matthew A. Getz sold 6,329 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $15.88, for a total value of $100,504.52. Following the completion of the transaction, the vice president now directly owns 30,387 shares in the […]
Form N-CSRS Series Portfolios Trust For: Mar 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Artivion, Inc. (NYSE:AORT – Get Rating) SVP Dennis B. Maier sold 16,254 shares of the company’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $15.27, for a total transaction of $248,198.58. Following the transaction, the senior vice president now owns 34,724 shares in the company, valued […]
ProSomnus (NASDAQ:OSA – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares ProSomnus and Artivion’s revenue, earnings […]
Artivion, Inc. (AORT) announced the FDA granted premarket application approval of PERCLOT Absorbable Hemostatic System for use to control bleeding in certain open and laparoscopic surgical procedures.